Neuropeptide Y Receptor Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Food Grade, and Pharmaceutical Grade); End Use (Medicine, Food Additives, and Others), and GeographyStimulation, and Vagus Nerve Stimulation); End Use (Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, and Others), and Geography

Report Code: TIPRE00022281 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Neuropeptide Y Receptor are class of G-Protein coupled receptors sensitive to closely associated peptide hormones such as peptide YY, pancreatic polypeptide, and neuropeptide Y. NPY is closely related to central mechanism involving obesity and food intake. These receptors are involved in different type of biological process. With the increase in prevalence of several diseases related to obesity, the neuropeptide y receptor market is growing.

MARKET DYNAMICS

Factors driving the growth of the neuropeptide y receptor market are high predominance of diseases related to obesity, and growing overweight populace. However, limited number of manufacturers and distribution channel is likely to hamper the growth of the market. Moreover, growing unhealthy urban lifestyle and sudden weight gain in the neuropeptide y receptor is further likely to create growth opportunities in the market.

MARKET SCOPE

The "Neuropeptide Y Receptor Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of neuropeptide y receptor market with detailed market segmentation by type of product and end use. The neuropeptide y receptor market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in neuropeptide y receptor market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The neuropeptide y receptor market is segmented on the basis of type of product and end use. On the basis of type of product, the market is categorized as food grade, and pharmaceutical grade. On the basis of end use, the market is categorized as medicine, food additives, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the neuropeptide y receptor market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuropeptide y receptor market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting neuropeptide y receptor market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the neuropeptide y receptor market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the neuropeptide y receptor market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from neuropeptide y receptor market are anticipated to have lucrative growth opportunities in the future with the rising demand for neuropeptide y receptor in the global market. Below mentioned is the list of few companies engaged in the neuropeptide y receptor market.

The report also includes the profiles of key players in neuropeptide y receptor market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

  •  Gila Therapeutics Inc
  •  Novo Nordisk A/S.
  •  XL-protein GmbH
  •  Novartis AG
  •  Pfizer Inc.
  •  Merck & Co., Inc
  •  Mannkind Corp.
  •  Gilead Sciences Inc
  •  Genentech, Inc.
  •  Lilly Eli

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neuropeptide Y Receptor Market - By Product
1.3.2 Neuropeptide Y Receptor Market - By End Use
1.3.3 Neuropeptide Y Receptor Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEUROPEPTIDE Y RECEPTOR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEUROPEPTIDE Y RECEPTOR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEUROPEPTIDE Y RECEPTOR MARKET - GLOBAL MARKET ANALYSIS
6.1. NEUROPEPTIDE Y RECEPTOR - GLOBAL MARKET OVERVIEW
6.2. NEUROPEPTIDE Y RECEPTOR - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NEUROPEPTIDE Y RECEPTOR MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. FOOD GRADE
7.3.1. Overview
7.3.2. Food Grade Market Forecast and Analysis
7.4. PHARMACEUTICAL GRADE
7.4.1. Overview
7.4.2. Pharmaceutical Grade Market Forecast and Analysis
8. NEUROPEPTIDE Y RECEPTOR MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. MEDICINE
8.3.1. Overview
8.3.2. Medicine Market Forecast and Analysis
8.4. FOOD ADDITIVES
8.4.1. Overview
8.4.2. Food Additives Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. NEUROPEPTIDE Y RECEPTOR MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Neuropeptide Y Receptor Market Overview
9.1.2 North America Neuropeptide Y Receptor Market Forecasts and Analysis
9.1.3 North America Neuropeptide Y Receptor Market Forecasts and Analysis - By Product
9.1.4 North America Neuropeptide Y Receptor Market Forecasts and Analysis - By End Use
9.1.5 North America Neuropeptide Y Receptor Market Forecasts and Analysis - By Countries
9.1.5.1 United States Neuropeptide Y Receptor Market
9.1.5.1.1 United States Neuropeptide Y Receptor Market by Product
9.1.5.1.2 United States Neuropeptide Y Receptor Market by End Use
9.1.5.2 Canada Neuropeptide Y Receptor Market
9.1.5.2.1 Canada Neuropeptide Y Receptor Market by Product
9.1.5.2.2 Canada Neuropeptide Y Receptor Market by End Use
9.1.5.3 Mexico Neuropeptide Y Receptor Market
9.1.5.3.1 Mexico Neuropeptide Y Receptor Market by Product
9.1.5.3.2 Mexico Neuropeptide Y Receptor Market by End Use
9.2. EUROPE
9.2.1 Europe Neuropeptide Y Receptor Market Overview
9.2.2 Europe Neuropeptide Y Receptor Market Forecasts and Analysis
9.2.3 Europe Neuropeptide Y Receptor Market Forecasts and Analysis - By Product
9.2.4 Europe Neuropeptide Y Receptor Market Forecasts and Analysis - By End Use
9.2.5 Europe Neuropeptide Y Receptor Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Neuropeptide Y Receptor Market
9.2.5.1.1 Germany Neuropeptide Y Receptor Market by Product
9.2.5.1.2 Germany Neuropeptide Y Receptor Market by End Use
9.2.5.2 France Neuropeptide Y Receptor Market
9.2.5.2.1 France Neuropeptide Y Receptor Market by Product
9.2.5.2.2 France Neuropeptide Y Receptor Market by End Use
9.2.5.3 Italy Neuropeptide Y Receptor Market
9.2.5.3.1 Italy Neuropeptide Y Receptor Market by Product
9.2.5.3.2 Italy Neuropeptide Y Receptor Market by End Use
9.2.5.4 Spain Neuropeptide Y Receptor Market
9.2.5.4.1 Spain Neuropeptide Y Receptor Market by Product
9.2.5.4.2 Spain Neuropeptide Y Receptor Market by End Use
9.2.5.5 United Kingdom Neuropeptide Y Receptor Market
9.2.5.5.1 United Kingdom Neuropeptide Y Receptor Market by Product
9.2.5.5.2 United Kingdom Neuropeptide Y Receptor Market by End Use
9.2.5.6 Rest of Europe Neuropeptide Y Receptor Market
9.2.5.6.1 Rest of Europe Neuropeptide Y Receptor Market by Product
9.2.5.6.2 Rest of Europe Neuropeptide Y Receptor Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Neuropeptide Y Receptor Market Overview
9.3.2 Asia-Pacific Neuropeptide Y Receptor Market Forecasts and Analysis
9.3.3 Asia-Pacific Neuropeptide Y Receptor Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Neuropeptide Y Receptor Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Neuropeptide Y Receptor Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Neuropeptide Y Receptor Market
9.3.5.1.1 Australia Neuropeptide Y Receptor Market by Product
9.3.5.1.2 Australia Neuropeptide Y Receptor Market by End Use
9.3.5.2 China Neuropeptide Y Receptor Market
9.3.5.2.1 China Neuropeptide Y Receptor Market by Product
9.3.5.2.2 China Neuropeptide Y Receptor Market by End Use
9.3.5.3 India Neuropeptide Y Receptor Market
9.3.5.3.1 India Neuropeptide Y Receptor Market by Product
9.3.5.3.2 India Neuropeptide Y Receptor Market by End Use
9.3.5.4 Japan Neuropeptide Y Receptor Market
9.3.5.4.1 Japan Neuropeptide Y Receptor Market by Product
9.3.5.4.2 Japan Neuropeptide Y Receptor Market by End Use
9.3.5.5 South Korea Neuropeptide Y Receptor Market
9.3.5.5.1 South Korea Neuropeptide Y Receptor Market by Product
9.3.5.5.2 South Korea Neuropeptide Y Receptor Market by End Use
9.3.5.6 Rest of Asia-Pacific Neuropeptide Y Receptor Market
9.3.5.6.1 Rest of Asia-Pacific Neuropeptide Y Receptor Market by Product
9.3.5.6.2 Rest of Asia-Pacific Neuropeptide Y Receptor Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Neuropeptide Y Receptor Market Overview
9.4.2 Middle East and Africa Neuropeptide Y Receptor Market Forecasts and Analysis
9.4.3 Middle East and Africa Neuropeptide Y Receptor Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Neuropeptide Y Receptor Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Neuropeptide Y Receptor Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Neuropeptide Y Receptor Market
9.4.5.1.1 South Africa Neuropeptide Y Receptor Market by Product
9.4.5.1.2 South Africa Neuropeptide Y Receptor Market by End Use
9.4.5.2 Saudi Arabia Neuropeptide Y Receptor Market
9.4.5.2.1 Saudi Arabia Neuropeptide Y Receptor Market by Product
9.4.5.2.2 Saudi Arabia Neuropeptide Y Receptor Market by End Use
9.4.5.3 U.A.E Neuropeptide Y Receptor Market
9.4.5.3.1 U.A.E Neuropeptide Y Receptor Market by Product
9.4.5.3.2 U.A.E Neuropeptide Y Receptor Market by End Use
9.4.5.4 Rest of Middle East and Africa Neuropeptide Y Receptor Market
9.4.5.4.1 Rest of Middle East and Africa Neuropeptide Y Receptor Market by Product
9.4.5.4.2 Rest of Middle East and Africa Neuropeptide Y Receptor Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Neuropeptide Y Receptor Market Overview
9.5.2 South and Central America Neuropeptide Y Receptor Market Forecasts and Analysis
9.5.3 South and Central America Neuropeptide Y Receptor Market Forecasts and Analysis - By Product
9.5.4 South and Central America Neuropeptide Y Receptor Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Neuropeptide Y Receptor Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Neuropeptide Y Receptor Market
9.5.5.1.1 Brazil Neuropeptide Y Receptor Market by Product
9.5.5.1.2 Brazil Neuropeptide Y Receptor Market by End Use
9.5.5.2 Argentina Neuropeptide Y Receptor Market
9.5.5.2.1 Argentina Neuropeptide Y Receptor Market by Product
9.5.5.2.2 Argentina Neuropeptide Y Receptor Market by End Use
9.5.5.3 Rest of South and Central America Neuropeptide Y Receptor Market
9.5.5.3.1 Rest of South and Central America Neuropeptide Y Receptor Market by Product
9.5.5.3.2 Rest of South and Central America Neuropeptide Y Receptor Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NEUROPEPTIDE Y RECEPTOR MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEUROPEPTIDE Y RECEPTOR MARKET, KEY COMPANY PROFILES
12.1. GILA THERAPEUTICS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVO NORDISK A/S
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. XL-PROTEIN GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MANKIND CORP
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GILEAD SCIENCES INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GENENTECH, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LILLY ELI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Gila Therapeutics Inc
2. Novo Nordisk A/S.
3. XL-protein GmbH
4. Novartis AG
5. Pfizer Inc.
6. Merck & Co., Inc
7. Mannkind Corp.
8. Gilead Sciences Inc
9. Genentech, Inc.
10. Lilly Eli
TIPRE00022281
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking